SlideShare a Scribd company logo
1 of 18
ASTHMA
MUAWIZ FAROOQI
GROUP 148
DEFINATION
• Asthma is a bronchonstriction present with wheeze
. It is (long-term) condition that affects the airways
in the lungs . It is reversible When using short
acting beta agonist
ETIOLOGY
1. Genetic
2. Allergen & Infection
3. Pollution
4. Smoking
5. Dust
6. Pollen
7. Bacteria virus
SYMPTOMS
• Shortness of breath.
• Chest tightness or pain.
• Wheezing when exhaling
• Cough (Especial At night )
• Difficulty breathing
TYPES OF ASTHMA
DAIGNOSE
• Spirometry
• bronchodilator tests
• Peak expiratory flow (PEF) tests.
• exhaled nitric oxide (FeNO) tests.
• Blood tests ( Check thd esinophil and IgE)
• Excercise
Blood tests
MANAGEMENT OF ASTHMA
Long term management
• Intermittent asthma is characterized by:
Infrequent symptoms
Child is normal in between attacks.
Treatment: Short acting beta agonists (as and when
needed).
PERSISTENT ASTHMA:
• mild persistent:
Day episode 2 a/month.
Night time awakening > 1/month.
Treat daily with low dose inhaled corticosteroids (ICS):
Budesonide, Fluticasone, Beclomethasone.
moderate persistent:
Daily attacks or need to use of SABA daily.
Treat with medium dose ICS or low dose ICS daily +
LABA (Long Acting Beta Agonist) like Salmeterol,
formoterol.
Severe persistent:
Daily attacks but continuous throughout day & night.
Significant limitation of physical activities.
Treatment: High dose ICS daily + LABA. Alternate choices (as add on
drugs for better control:
•montelukast ,Sustained release theophyline Oral short course steroid
ASTHMA MEDICATION DEVICE
MANAGEMENT OF ACUTE ATTACKS OF ASTHMA:
(MDI/nebulizer) One puff every minute (10 puffs ) Single
nebulisation
If respone PEFR Incresae 80
If no responce
Give 0 if Spo <95% Start oral prednisolone (1-2 mg/kg)
After 1 hour Assess
If Responce
Continue SABA every 6-8 hoursfor next 24 hours
If no responce
Nebulisation of salbutamol +Ipratropium + Inj.
Hydrocortisone
(10 mg/kg)
ASSESS AFTER 2 HOURS
Look for response
SABA
Oral prednisolone for 5 days
No response
Inj. Theophylline + IV magnesium sulfate infusion
No response
mechanical ventilation
LIFE THREATENING ASTHMA
• child presenting with:
Silent chest.
Cyanosis.
Altered sensorium
Poor respiratory efforts/laboured breathing.
Spoa < 90%.
PEFR < 30% of expected
TREATMENT
Injection Adrenaline/Terbutaline subcutaneously.
Injection Hydrocortisone.
Neb. Salbutamol + Ipratropium
•Thankyou

More Related Content

Similar to Asthma.pptx

Asthma Review - GINA guidelines summary 2024
Asthma Review - GINA guidelines summary 2024Asthma Review - GINA guidelines summary 2024
Asthma Review - GINA guidelines summary 2024Gabriel Guevara MD
 
5. Bronchial asthma treatment and prognosis .pdf
5. Bronchial asthma  treatment and prognosis  .pdf5. Bronchial asthma  treatment and prognosis  .pdf
5. Bronchial asthma treatment and prognosis .pdfShinilLenin
 
Childhood asthma diagnosis and management
Childhood asthma diagnosis and managementChildhood asthma diagnosis and management
Childhood asthma diagnosis and managementVirendra Hindustani
 
Acute severe asthma management 2020
Acute severe asthma management 2020Acute severe asthma management 2020
Acute severe asthma management 2020Mohamed Metwally
 
Management of Asthma at Primary Care Level
Management of Asthma at Primary Care LevelManagement of Asthma at Primary Care Level
Management of Asthma at Primary Care LevelRedzwan Abdullah
 
Airways obstruction (Bronchial Asthma).pptx
Airways obstruction (Bronchial Asthma).pptxAirways obstruction (Bronchial Asthma).pptx
Airways obstruction (Bronchial Asthma).pptxZubbi1
 
Internal medicine review for national license examination 2
Internal medicine review for national license examination 2 Internal medicine review for national license examination 2
Internal medicine review for national license examination 2 Santi Silairatana
 
Asthma Module 1 session 2 | 24/03/201 | All
Asthma Module 1 session 2 | 24/03/201 | All Asthma Module 1 session 2 | 24/03/201 | All
Asthma Module 1 session 2 | 24/03/201 | All NES
 
Asthma.pptx(disease or medical condition)
Asthma.pptx(disease or medical condition)Asthma.pptx(disease or medical condition)
Asthma.pptx(disease or medical condition)Niraj83
 
ASTHMA and it's Physiotherapy Treatment.pptx
ASTHMA  and it's Physiotherapy Treatment.pptxASTHMA  and it's Physiotherapy Treatment.pptx
ASTHMA and it's Physiotherapy Treatment.pptxShilpasree Saha
 
Treatment of Bronchial asthma
Treatment of Bronchial asthma Treatment of Bronchial asthma
Treatment of Bronchial asthma Ahmed Elberry
 

Similar to Asthma.pptx (20)

asthma .pptx
asthma  .pptxasthma  .pptx
asthma .pptx
 
Asthma Review - GINA guidelines summary 2024
Asthma Review - GINA guidelines summary 2024Asthma Review - GINA guidelines summary 2024
Asthma Review - GINA guidelines summary 2024
 
5. Bronchial asthma treatment and prognosis .pdf
5. Bronchial asthma  treatment and prognosis  .pdf5. Bronchial asthma  treatment and prognosis  .pdf
5. Bronchial asthma treatment and prognosis .pdf
 
Pink Puffer Kids Final
Pink Puffer Kids FinalPink Puffer Kids Final
Pink Puffer Kids Final
 
Asthuma in children
Asthuma in childrenAsthuma in children
Asthuma in children
 
Asthma.pptx
Asthma.pptxAsthma.pptx
Asthma.pptx
 
Childhood asthma diagnosis and management
Childhood asthma diagnosis and managementChildhood asthma diagnosis and management
Childhood asthma diagnosis and management
 
Acute severe asthma management 2020
Acute severe asthma management 2020Acute severe asthma management 2020
Acute severe asthma management 2020
 
Management of Asthma at Primary Care Level
Management of Asthma at Primary Care LevelManagement of Asthma at Primary Care Level
Management of Asthma at Primary Care Level
 
Childhood asthma
Childhood asthmaChildhood asthma
Childhood asthma
 
Asthma
AsthmaAsthma
Asthma
 
Airways obstruction (Bronchial Asthma).pptx
Airways obstruction (Bronchial Asthma).pptxAirways obstruction (Bronchial Asthma).pptx
Airways obstruction (Bronchial Asthma).pptx
 
Internal medicine review for national license examination 2
Internal medicine review for national license examination 2 Internal medicine review for national license examination 2
Internal medicine review for national license examination 2
 
Asthma Module 1 session 2 | 24/03/201 | All
Asthma Module 1 session 2 | 24/03/201 | All Asthma Module 1 session 2 | 24/03/201 | All
Asthma Module 1 session 2 | 24/03/201 | All
 
Asthma.pptx(disease or medical condition)
Asthma.pptx(disease or medical condition)Asthma.pptx(disease or medical condition)
Asthma.pptx(disease or medical condition)
 
ASTHMA and it's Physiotherapy Treatment.pptx
ASTHMA  and it's Physiotherapy Treatment.pptxASTHMA  and it's Physiotherapy Treatment.pptx
ASTHMA and it's Physiotherapy Treatment.pptx
 
Recent advances in the management of bronchial asthma
Recent advances in the management of bronchial asthmaRecent advances in the management of bronchial asthma
Recent advances in the management of bronchial asthma
 
Treatment of Bronchial asthma
Treatment of Bronchial asthma Treatment of Bronchial asthma
Treatment of Bronchial asthma
 
Asthma
Asthma Asthma
Asthma
 
Asthma management 2
Asthma management 2Asthma management 2
Asthma management 2
 

More from shiv847105

Glomerulonephritis topic kidney related disease
Glomerulonephritis topic kidney related diseaseGlomerulonephritis topic kidney related disease
Glomerulonephritis topic kidney related diseaseshiv847105
 
Peptic Ulcer complications By Abdullah Farooqi GM20-148.pptx
Peptic Ulcer complications By Abdullah Farooqi GM20-148.pptxPeptic Ulcer complications By Abdullah Farooqi GM20-148.pptx
Peptic Ulcer complications By Abdullah Farooqi GM20-148.pptxshiv847105
 
hassan iqbal- AMD..ppsx
hassan iqbal- AMD..ppsxhassan iqbal- AMD..ppsx
hassan iqbal- AMD..ppsxshiv847105
 
L6_TONSILLITIS.-ADENOIDS.-TONSILLAR-HYPERTROPHY-LECTURE.pdf
L6_TONSILLITIS.-ADENOIDS.-TONSILLAR-HYPERTROPHY-LECTURE.pdfL6_TONSILLITIS.-ADENOIDS.-TONSILLAR-HYPERTROPHY-LECTURE.pdf
L6_TONSILLITIS.-ADENOIDS.-TONSILLAR-HYPERTROPHY-LECTURE.pdfshiv847105
 
Kunal Singh .Topic-4.Diseases of the larynx.ENT.GM20-148.pptx
Kunal Singh .Topic-4.Diseases of the larynx.ENT.GM20-148.pptxKunal Singh .Topic-4.Diseases of the larynx.ENT.GM20-148.pptx
Kunal Singh .Topic-4.Diseases of the larynx.ENT.GM20-148.pptxshiv847105
 
bronchialasthma-160504062522.pptx
bronchialasthma-160504062522.pptxbronchialasthma-160504062522.pptx
bronchialasthma-160504062522.pptxshiv847105
 
Quarintable infection.pptx
Quarintable infection.pptxQuarintable infection.pptx
Quarintable infection.pptxshiv847105
 
Movement module.ppt
Movement module.pptMovement module.ppt
Movement module.pptshiv847105
 

More from shiv847105 (8)

Glomerulonephritis topic kidney related disease
Glomerulonephritis topic kidney related diseaseGlomerulonephritis topic kidney related disease
Glomerulonephritis topic kidney related disease
 
Peptic Ulcer complications By Abdullah Farooqi GM20-148.pptx
Peptic Ulcer complications By Abdullah Farooqi GM20-148.pptxPeptic Ulcer complications By Abdullah Farooqi GM20-148.pptx
Peptic Ulcer complications By Abdullah Farooqi GM20-148.pptx
 
hassan iqbal- AMD..ppsx
hassan iqbal- AMD..ppsxhassan iqbal- AMD..ppsx
hassan iqbal- AMD..ppsx
 
L6_TONSILLITIS.-ADENOIDS.-TONSILLAR-HYPERTROPHY-LECTURE.pdf
L6_TONSILLITIS.-ADENOIDS.-TONSILLAR-HYPERTROPHY-LECTURE.pdfL6_TONSILLITIS.-ADENOIDS.-TONSILLAR-HYPERTROPHY-LECTURE.pdf
L6_TONSILLITIS.-ADENOIDS.-TONSILLAR-HYPERTROPHY-LECTURE.pdf
 
Kunal Singh .Topic-4.Diseases of the larynx.ENT.GM20-148.pptx
Kunal Singh .Topic-4.Diseases of the larynx.ENT.GM20-148.pptxKunal Singh .Topic-4.Diseases of the larynx.ENT.GM20-148.pptx
Kunal Singh .Topic-4.Diseases of the larynx.ENT.GM20-148.pptx
 
bronchialasthma-160504062522.pptx
bronchialasthma-160504062522.pptxbronchialasthma-160504062522.pptx
bronchialasthma-160504062522.pptx
 
Quarintable infection.pptx
Quarintable infection.pptxQuarintable infection.pptx
Quarintable infection.pptx
 
Movement module.ppt
Movement module.pptMovement module.ppt
Movement module.ppt
 

Recently uploaded

Key note speaker Neum_Admir Softic_ENG.pdf
Key note speaker Neum_Admir Softic_ENG.pdfKey note speaker Neum_Admir Softic_ENG.pdf
Key note speaker Neum_Admir Softic_ENG.pdfAdmir Softic
 
ICT role in 21st century education and it's challenges.
ICT role in 21st century education and it's challenges.ICT role in 21st century education and it's challenges.
ICT role in 21st century education and it's challenges.MaryamAhmad92
 
Holdier Curriculum Vitae (April 2024).pdf
Holdier Curriculum Vitae (April 2024).pdfHoldier Curriculum Vitae (April 2024).pdf
Holdier Curriculum Vitae (April 2024).pdfagholdier
 
Sociology 101 Demonstration of Learning Exhibit
Sociology 101 Demonstration of Learning ExhibitSociology 101 Demonstration of Learning Exhibit
Sociology 101 Demonstration of Learning Exhibitjbellavia9
 
Class 11th Physics NEET formula sheet pdf
Class 11th Physics NEET formula sheet pdfClass 11th Physics NEET formula sheet pdf
Class 11th Physics NEET formula sheet pdfAyushMahapatra5
 
Unit-IV; Professional Sales Representative (PSR).pptx
Unit-IV; Professional Sales Representative (PSR).pptxUnit-IV; Professional Sales Representative (PSR).pptx
Unit-IV; Professional Sales Representative (PSR).pptxVishalSingh1417
 
PROCESS RECORDING FORMAT.docx
PROCESS      RECORDING        FORMAT.docxPROCESS      RECORDING        FORMAT.docx
PROCESS RECORDING FORMAT.docxPoojaSen20
 
Basic Civil Engineering first year Notes- Chapter 4 Building.pptx
Basic Civil Engineering first year Notes- Chapter 4 Building.pptxBasic Civil Engineering first year Notes- Chapter 4 Building.pptx
Basic Civil Engineering first year Notes- Chapter 4 Building.pptxDenish Jangid
 
Application orientated numerical on hev.ppt
Application orientated numerical on hev.pptApplication orientated numerical on hev.ppt
Application orientated numerical on hev.pptRamjanShidvankar
 
Role Of Transgenic Animal In Target Validation-1.pptx
Role Of Transgenic Animal In Target Validation-1.pptxRole Of Transgenic Animal In Target Validation-1.pptx
Role Of Transgenic Animal In Target Validation-1.pptxNikitaBankoti2
 
Unit-V; Pricing (Pharma Marketing Management).pptx
Unit-V; Pricing (Pharma Marketing Management).pptxUnit-V; Pricing (Pharma Marketing Management).pptx
Unit-V; Pricing (Pharma Marketing Management).pptxVishalSingh1417
 
This PowerPoint helps students to consider the concept of infinity.
This PowerPoint helps students to consider the concept of infinity.This PowerPoint helps students to consider the concept of infinity.
This PowerPoint helps students to consider the concept of infinity.christianmathematics
 
2024-NATIONAL-LEARNING-CAMP-AND-OTHER.pptx
2024-NATIONAL-LEARNING-CAMP-AND-OTHER.pptx2024-NATIONAL-LEARNING-CAMP-AND-OTHER.pptx
2024-NATIONAL-LEARNING-CAMP-AND-OTHER.pptxMaritesTamaniVerdade
 
Python Notes for mca i year students osmania university.docx
Python Notes for mca i year students osmania university.docxPython Notes for mca i year students osmania university.docx
Python Notes for mca i year students osmania university.docxRamakrishna Reddy Bijjam
 
Micro-Scholarship, What it is, How can it help me.pdf
Micro-Scholarship, What it is, How can it help me.pdfMicro-Scholarship, What it is, How can it help me.pdf
Micro-Scholarship, What it is, How can it help me.pdfPoh-Sun Goh
 
psychiatric nursing HISTORY COLLECTION .docx
psychiatric  nursing HISTORY  COLLECTION  .docxpsychiatric  nursing HISTORY  COLLECTION  .docx
psychiatric nursing HISTORY COLLECTION .docxPoojaSen20
 
Beyond the EU: DORA and NIS 2 Directive's Global Impact
Beyond the EU: DORA and NIS 2 Directive's Global ImpactBeyond the EU: DORA and NIS 2 Directive's Global Impact
Beyond the EU: DORA and NIS 2 Directive's Global ImpactPECB
 
Grant Readiness 101 TechSoup and Remy Consulting
Grant Readiness 101 TechSoup and Remy ConsultingGrant Readiness 101 TechSoup and Remy Consulting
Grant Readiness 101 TechSoup and Remy ConsultingTechSoup
 

Recently uploaded (20)

Mehran University Newsletter Vol-X, Issue-I, 2024
Mehran University Newsletter Vol-X, Issue-I, 2024Mehran University Newsletter Vol-X, Issue-I, 2024
Mehran University Newsletter Vol-X, Issue-I, 2024
 
Key note speaker Neum_Admir Softic_ENG.pdf
Key note speaker Neum_Admir Softic_ENG.pdfKey note speaker Neum_Admir Softic_ENG.pdf
Key note speaker Neum_Admir Softic_ENG.pdf
 
ICT role in 21st century education and it's challenges.
ICT role in 21st century education and it's challenges.ICT role in 21st century education and it's challenges.
ICT role in 21st century education and it's challenges.
 
Holdier Curriculum Vitae (April 2024).pdf
Holdier Curriculum Vitae (April 2024).pdfHoldier Curriculum Vitae (April 2024).pdf
Holdier Curriculum Vitae (April 2024).pdf
 
Sociology 101 Demonstration of Learning Exhibit
Sociology 101 Demonstration of Learning ExhibitSociology 101 Demonstration of Learning Exhibit
Sociology 101 Demonstration of Learning Exhibit
 
Class 11th Physics NEET formula sheet pdf
Class 11th Physics NEET formula sheet pdfClass 11th Physics NEET formula sheet pdf
Class 11th Physics NEET formula sheet pdf
 
Unit-IV; Professional Sales Representative (PSR).pptx
Unit-IV; Professional Sales Representative (PSR).pptxUnit-IV; Professional Sales Representative (PSR).pptx
Unit-IV; Professional Sales Representative (PSR).pptx
 
Asian American Pacific Islander Month DDSD 2024.pptx
Asian American Pacific Islander Month DDSD 2024.pptxAsian American Pacific Islander Month DDSD 2024.pptx
Asian American Pacific Islander Month DDSD 2024.pptx
 
PROCESS RECORDING FORMAT.docx
PROCESS      RECORDING        FORMAT.docxPROCESS      RECORDING        FORMAT.docx
PROCESS RECORDING FORMAT.docx
 
Basic Civil Engineering first year Notes- Chapter 4 Building.pptx
Basic Civil Engineering first year Notes- Chapter 4 Building.pptxBasic Civil Engineering first year Notes- Chapter 4 Building.pptx
Basic Civil Engineering first year Notes- Chapter 4 Building.pptx
 
Application orientated numerical on hev.ppt
Application orientated numerical on hev.pptApplication orientated numerical on hev.ppt
Application orientated numerical on hev.ppt
 
Role Of Transgenic Animal In Target Validation-1.pptx
Role Of Transgenic Animal In Target Validation-1.pptxRole Of Transgenic Animal In Target Validation-1.pptx
Role Of Transgenic Animal In Target Validation-1.pptx
 
Unit-V; Pricing (Pharma Marketing Management).pptx
Unit-V; Pricing (Pharma Marketing Management).pptxUnit-V; Pricing (Pharma Marketing Management).pptx
Unit-V; Pricing (Pharma Marketing Management).pptx
 
This PowerPoint helps students to consider the concept of infinity.
This PowerPoint helps students to consider the concept of infinity.This PowerPoint helps students to consider the concept of infinity.
This PowerPoint helps students to consider the concept of infinity.
 
2024-NATIONAL-LEARNING-CAMP-AND-OTHER.pptx
2024-NATIONAL-LEARNING-CAMP-AND-OTHER.pptx2024-NATIONAL-LEARNING-CAMP-AND-OTHER.pptx
2024-NATIONAL-LEARNING-CAMP-AND-OTHER.pptx
 
Python Notes for mca i year students osmania university.docx
Python Notes for mca i year students osmania university.docxPython Notes for mca i year students osmania university.docx
Python Notes for mca i year students osmania university.docx
 
Micro-Scholarship, What it is, How can it help me.pdf
Micro-Scholarship, What it is, How can it help me.pdfMicro-Scholarship, What it is, How can it help me.pdf
Micro-Scholarship, What it is, How can it help me.pdf
 
psychiatric nursing HISTORY COLLECTION .docx
psychiatric  nursing HISTORY  COLLECTION  .docxpsychiatric  nursing HISTORY  COLLECTION  .docx
psychiatric nursing HISTORY COLLECTION .docx
 
Beyond the EU: DORA and NIS 2 Directive's Global Impact
Beyond the EU: DORA and NIS 2 Directive's Global ImpactBeyond the EU: DORA and NIS 2 Directive's Global Impact
Beyond the EU: DORA and NIS 2 Directive's Global Impact
 
Grant Readiness 101 TechSoup and Remy Consulting
Grant Readiness 101 TechSoup and Remy ConsultingGrant Readiness 101 TechSoup and Remy Consulting
Grant Readiness 101 TechSoup and Remy Consulting
 

Asthma.pptx

  • 2. DEFINATION • Asthma is a bronchonstriction present with wheeze . It is (long-term) condition that affects the airways in the lungs . It is reversible When using short acting beta agonist
  • 3. ETIOLOGY 1. Genetic 2. Allergen & Infection 3. Pollution 4. Smoking 5. Dust 6. Pollen 7. Bacteria virus
  • 4. SYMPTOMS • Shortness of breath. • Chest tightness or pain. • Wheezing when exhaling • Cough (Especial At night ) • Difficulty breathing
  • 6. DAIGNOSE • Spirometry • bronchodilator tests • Peak expiratory flow (PEF) tests. • exhaled nitric oxide (FeNO) tests. • Blood tests ( Check thd esinophil and IgE) • Excercise Blood tests
  • 7. MANAGEMENT OF ASTHMA Long term management • Intermittent asthma is characterized by: Infrequent symptoms Child is normal in between attacks. Treatment: Short acting beta agonists (as and when needed).
  • 8. PERSISTENT ASTHMA: • mild persistent: Day episode 2 a/month. Night time awakening > 1/month. Treat daily with low dose inhaled corticosteroids (ICS): Budesonide, Fluticasone, Beclomethasone.
  • 9. moderate persistent: Daily attacks or need to use of SABA daily. Treat with medium dose ICS or low dose ICS daily + LABA (Long Acting Beta Agonist) like Salmeterol, formoterol.
  • 10. Severe persistent: Daily attacks but continuous throughout day & night. Significant limitation of physical activities. Treatment: High dose ICS daily + LABA. Alternate choices (as add on drugs for better control: •montelukast ,Sustained release theophyline Oral short course steroid
  • 12.
  • 13. MANAGEMENT OF ACUTE ATTACKS OF ASTHMA: (MDI/nebulizer) One puff every minute (10 puffs ) Single nebulisation If respone PEFR Incresae 80 If no responce Give 0 if Spo <95% Start oral prednisolone (1-2 mg/kg) After 1 hour Assess
  • 14. If Responce Continue SABA every 6-8 hoursfor next 24 hours If no responce Nebulisation of salbutamol +Ipratropium + Inj. Hydrocortisone (10 mg/kg)
  • 15. ASSESS AFTER 2 HOURS Look for response SABA Oral prednisolone for 5 days No response Inj. Theophylline + IV magnesium sulfate infusion No response mechanical ventilation
  • 16. LIFE THREATENING ASTHMA • child presenting with: Silent chest. Cyanosis. Altered sensorium Poor respiratory efforts/laboured breathing. Spoa < 90%. PEFR < 30% of expected
  • 17. TREATMENT Injection Adrenaline/Terbutaline subcutaneously. Injection Hydrocortisone. Neb. Salbutamol + Ipratropium